Oscar Health Inc
(MEX:OSCR)
MXN
536
+18 (+3.47%)
Market Cap: 161.61 Bil
Enterprise Value: 85.46 Bil
PE Ratio: 0
PB Ratio: 5.53
GF Score: 53/100 Q4 2024 Oscar Health Inc Earnings Call Transcript
Feb 04, 2025 / 10:00PM GMT
Key Points
Positve
- Oscar Health Inc (OSCR) reported its strongest financial performance in history, achieving adjusted EBITDA profitability of $100 million, a $245 million improvement year-over-year.
- The company achieved net income profitability for the first time, with a net income of $25 million, marking a $296 million increase over the previous year.
- Total revenue grew by 57% year-over-year to $9.2 billion, driven by record high membership and strong retention.
- Oscar Health Inc (OSCR) experienced significant market share gains, particularly in key states like Florida, Tennessee, and Texas, and performed well in new geographies such as North Carolina.
- The company's technology platform, with AI integration, is enhancing operational efficiency and member engagement, reducing provider administrative tasks, and improving care delivery.
Negative
- The fourth quarter medical loss ratio (MLR) increased by 170 basis points year-over-year, indicating some pressure on profitability.
- Oscar Health Inc (OSCR) faced challenges with risk adjustment settlements, which impacted both MLR and revenue.
- The company anticipates a 9.1% impact of effectuation against actual paying members, reflecting potential enrollment declines.
- There is a potential risk of attrition throughout the year as members may gain employment or stop paying premiums.
- Oscar Health Inc (OSCR) is making investments in SG&A to accelerate growth, which may impact short-term profitability despite long-term benefits.
Operator
Good evening. My name is Rob, and I will be your conference operator today. At this time, I would like to welcome everyone to Oscar Health's fourth quarter and full year 2024 earnings conference call. (Operator Instructions)
I will now turn the conference over to Chris Potochar, Vice President of Treasury and Investor Relations.
Chris Potochar
Oscar Health Inc - VP of Investor Relations
Good evening everyone. Thank you for joining us for our fourth quarter and full year 2024 earnings call. Mark Bertolini, Oscar's Chief Executive Officer; and
Full details of our results and
Already have an account? Log in
Get the full story
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
7-Day Free Trial · Cancel Anytime
Subscription fee may be tax deductible.
Excellent 

4.6 out of 5
Trustpilot